Ruziana Mona Wan Mohd Zin

Ruziana Mona Wan Mohd Zin

Auto-generated profile, based on publicly available information

Ruziana Mona Wan Mohd Zin

Department of Pediatrics, Faculty of Medicine, University of Malaya, University of Malaya, Wilayah Persekutuan Kuala Lumpur, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2024 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
RZRuziana Mona Wan Mohd Zin
Ruziana Mona Wan Mohd Zin
Muhammad Yazid JalaludinMuhammad Yazid Jalaludin
Muhammad Yazid Jalaludin
FZFuziah Md Zain
Fuziah Md Zain
JHJanet Yeow Hua Hong
Janet Yeow Hua Hong
NKNur Zati Iwani Ahmad Kamil
Nur Zati Iwani Ahmad Kamil
WMWan Nazaimoon Wan Mohamud
Wan Nazaimoon Wan Mohamud
Background: In recent years, there has been a surge of interest in the metabolic phenotype among children with obesity characterized by the absence of associated cardiometabolic risk factors (CRFs), known as metabolically healthy obesity (MHO), as opposed to those with metabolically unhealthy obesity (MUO). This study investigated the effect of lifestyle intervention on CRFs among children with MHO and MUO. Methods: A total of 102 school-aged children with obesity (54 girls and 48 boys) aged 8–16 years completed a 16-week school-based lifestyle modification intervention program, MyBFF@school Phase I. The intervention consisted of physical activity, healthy eating promotion, and psychological empowerment. MHO and MUO statuses were defined based on the 2018 consensus-based criteria. Fasting venous blood collection, body composition measurement, clinical assessment and physical fitness testing were conducted at baseline and at the end of week 16. Results: After the intervention, the CRFs of the children with MUO improved with significant decreases in systolic (p < 0.001) and diastolic (p = 0.01) blood pressure and a significant increase in high-density lipoprotein cholesterol (HDL-C) (p = 0.005), while the CRFs of the children with MHO had a significant decrease in uric acid (p = 0.04). Additionally, 51.6% of the children with MHO transitioned to the MUO, while 26.8% of the children with MUO crossed over to the MHO at the end of the intervention. Furthermore, the odds of having high systolic blood pressure among children with MUO were 59% lower at week-16 than at baseline (OR = 0.41 (95% CI = 0.18, 0.92), p = 0.03). Conclusions: Our findings demonstrated that CRFs improved more prominently among children with MUO following the intervention. More importantly, our findings indicate that MHO in children is transient, hence, strategies to protect children against MUO are warranted. Trial registration: ClinicalTrials.gov NCT02212873.

5 August 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
SAShazana Rifham Abdullah
Shazana Rifham Abdullah
NANur Hayati Azizul
Nur Hayati Azizul
RZRuziana Mona Wan Mohd Zin
Ruziana Mona Wan Mohd Zin
NSNur Suffia Sulaiman
Nur Suffia Sulaiman
NKNorhayati Mustafa Khalid
Norhayati Mustafa Khalid
MNMohd Fairulnizal Md Noh
Mohd Fairulnizal Md Noh
Background: Overweight and obesity among adults are a growing global public health threat and an essential risk factor for various noncommunicable diseases. Although intermittent fasting is a generally new dietary approach to weight management that has been increasingly practiced worldwide, the effectiveness of 2 days per week dry fasting remains unclear. Objective: The Cardiometabolic and Anthropometric Outcomes of Intermittent Fasting study aims to determine the cardiometabolic, anthropometric, dietary intake, and quality of life changes among civil servants with overweight and obesity, following combined intermittent fasting and healthy plate (IFHP) and healthy plate (HP) and explore the participants’ experiences. Methods: We designed a mixed methods quasi-experimental study to evaluate the effectiveness of the IFHP and HP methods among adults with overweight and obesity. A total of 177 participants were recruited for this study, of which 91 (51.4%) were allocated to the IFHP group and 86 (48.6%) to the HP group. The intervention comprised 2 phases: supervised (12 weeks) and unsupervised (12 weeks). Data collection was conducted at baseline, after the supervised phase (week 12), and after the unsupervised phase (week 24). Serum and whole blood samples were collected from each participant for analysis. Data on sociodemographic factors, quality of life, physical activity, and dietary intake were also obtained using questionnaires during data collection. Results: Most of the participants were female (147/177, 83.1%) and Malay (141/177, 79.7%). The expected outcomes of this study are changes in body weight, body composition, quality of life, physical activity, dietary intake, and cardiometabolic parameters such as fasting blood glucose, 2-hour postprandial blood glucose, hemoglobin A1c, fasting insulin, and lipid profile. Conclusions: The Cardiometabolic and Anthropometric Outcomes of Intermittent Fasting study is a mixed methods study to evaluate the effectiveness of combined IFHP and HP interventions on cardiometabolic and anthropometric parameters and explore participants’ experiences throughout the study. Trial Registration: ClinicalTrials.gov NCT05034653; https://clinicaltrials.gov/ct2/show/NCT05034653 International Registered Report Identifier (IRRID): RR1-10.2196/33801

10 April 2024 in JMIR Formative Research
Verified
Journal Article
Open access
SAShazana Rifham Abdullah
Shazana Rifham Abdullah
RZRuziana Mona Wan Mohd Zin
Ruziana Mona Wan Mohd Zin
NANur Hayati Azizul
Nur Hayati Azizul
NSNur Suffia Sulaiman
Nur Suffia Sulaiman
NKNorhayati Mustafa Khalid
Norhayati Mustafa Khalid
MNMohd Fairulnizal Md Noh
Mohd Fairulnizal Md Noh
Background: Adult obesity and overweight pose a substantial risk to global public health and are associated with various noncommunicable diseases. Although intermittent fasting (IF) is increasingly used as a relatively new dietary strategy for weight loss, the effectiveness of 2 days per week of dry fasting remains unknown. Objective: This study aims to evaluate the effectiveness of a combined dry IF and healthy plate (IFHP) and healthy plate (HP) intervention in improving anthropometric outcomes and body composition. Methods: This nonrandomized controlled trial involved 177 adults who were overweight and obese. Among them, 91 (51.4%) were allocated to the IFHP group and 86 (48.6%) were allocated to the HP group. The overall study duration was 6 months (October 2020 to March 2021). The intervention was divided into 2 phases: supervised (3 months) and unsupervised (3 months). The data were collected at baseline, after the supervised phase (month 3), and after the unsupervised phase (month 6). Anthropometric (weight, height, waist circumference, and hip circumference) and body composition (body fat percentage, body fat mass, skeletal muscle mass, and visceral fat area) data were measured at all 3 data collection points. Sociodemographic data were obtained using a questionnaire at baseline. Results: Most participants were female (147/177, 83.1%) and Malay (141/177, 79.7%). After 3 months, there were significant reductions in weight (difference −1.68; P<.001), BMI (difference −0.62; P<.001), body fat percentage (difference −0.921; P<.001), body fat mass (difference −1.28; P<.001), and visceral fat area (difference −4.227; P=.008) in the IFHP group, whereas no significant changes were observed in the HP group. Compared to baseline, participants in the IFHP group showed a significant decrease in weight (difference −1.428; P=.003), BMI (difference −0.522; P=.005), body fat percentage (difference −1.591; P<.001), body fat mass (difference −1.501; P<.001), visceral fat area (difference −7.130; P<.001), waist circumference (difference −2.304; P=.001), and hip circumference (difference −1.908; P=.002) at month 6. During the unsupervised phase, waist (IFHP difference −3.206; P<.001, HP difference −2.675; P=.004) and hip (IFHP difference −2.443; P<.001; HP difference −2.896; P<.001) circumferences were significantly reduced in both groups (P<.01), whereas skeletal muscle mass (difference 0.208; P=.04) and visceral fat area (difference −2.903; P=.003) were significantly improved in the IFHP group only. No significant difference in the between-group comparison was detected throughout the intervention (all P>.05). Conclusions: A combined IFHP intervention was effective in improving anthropometric outcomes and body composition in adults with overweight and obesity. International Registered Report Identifier (IRRID): RR2-10.2196/33801.

1 January 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
Muhammad Yazid JalaludinMuhammad Yazid Jalaludin
Muhammad Yazid Jalaludin
FRFarah Aqilah Roslan
Farah Aqilah Roslan
FMFazliana Mansor
Fazliana Mansor
FZFuziah Md. Zain
Fuziah Md. Zain
JHJanet Yeow Hua Hong
Janet Yeow Hua Hong
AMAbdul Halim Mokhtar
Abdul Halim Mokhtar
Background: Type 2 diabetes, hypertension, and dyslipidemia are comorbidities associated with obesity in children and adolescents. This school-based, cluster-randomized controlled study evaluated the effectiveness of a 6-month intervention (MyBFF@school) on cardiometabolic markers among overweight and obese Malaysian adolescents. Methods: This study involved proportionate stratified random sampling of government schools in three selected states in Malaysia. Fifteen out of 416 schools were selected. Schoolchildren aged 13–16 years with body mass index (BMI) z-score greater than + 1 SD (WHO) were recruited. The outcome measures included fasting plasma glucose, fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), lipid profiles, TG:HDL-C ratio and blood pressure.. Repeated measures ANOVA and ANCOVA were used to assess within- and between-group effects. Results: From 1041 adolescents, 552 (intervention = 306 and control = 246) had complete fasting bloods taken at baseline and month˗6. BMI z-scores decreased significantly within both groups, but no between-group differences were observed. Notably, BMI increased (albeit small) within the intervention group compared with baseline (mean difference (MD) 0.17 kg/m 2 ; 95% confident interval (CI) 0.02, 0.32) . A greater increase of HDL-C was observed in the intervention group at month-6 (MD = 0.06 mmol/L, 95% CI0.10,0.20). Fasting insulin was significantly decreased within the intervention group (MD = − 2.24 μU/mL (95% CI − 3.37, − 1.17) but no significant changes were detected between groups. Unexpectedly, fasting plasma glucose showed significant increase in both groups post-intervention (MD = 0.38, 95%CI 0.28,0.48). Similarly, although within normal range, significant increase of total cholesterol, TG and LDL-C, (MD = 0.36, 95%CI 0.25,0.47, MD = 0.26 95%CI 0.17,0.35 and MD = 0.30 95%CI 0.18,0.42 respectively) was observed. Additionally, significant increase of systolic and diastolic blood pressure was observed in the intervention group post- intervention compared to control group (MD = 3.68 95%CI 2.01,5.35 and MD = 4.29 95%CI 2.85,5.73) respectively. Conclusion: The MyBFF@school programme, resulted in reductions in BMI z-score in both groups; however, increases in BMI and several cardiometabolic markers were also observed within the intervention group. These mixed findings underscore the importance of evaluating both anthropometric and metabolic outcomes when assessing the effectiveness and safety of obesity interventions in adolescents. Trial registration: Clinical trial number: NCT04155255, November 7, 2019 (Retrospective registered). National Medical Research Register: NMRR-13–439-16563. Registered July 23, 2013. The intervention program was approved by the Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia and Educational Planning and Research Division (EPRD), Ministry of Education Malaysia. It was funded by the Ministry of Health Malaysia.

3 August 2023 in JMIR Preprints
Verified
Preprint
Open access
SAShazana Rifham Abdullah
Shazana Rifham Abdullah
RZRuziana Mona Wan Mohd Zin
Ruziana Mona Wan Mohd Zin
NANur Hayati Azizul
Nur Hayati Azizul
NSNur Suffia Sulaiman
Nur Suffia Sulaiman
NKNorhayati Mustafa Khalid
Norhayati Mustafa Khalid
MNMohd Fairulnizal Md Noh
Mohd Fairulnizal Md Noh
BACKGROUND Adult obesity and overweight pose a substantial risk to global public health and are associated with various noncommunicable diseases. Although intermittent fasting (IF) is increasingly used as a relatively new dietary strategy for weight loss, the effectiveness of 2 days per week of dry fasting remains unknown. OBJECTIVE This study aims to evaluate the effectiveness of a combined dry IF and healthy plate (IFHP) and healthy plate (HP) intervention in improving anthropometric outcomes and body composition. METHODS This nonrandomized controlled trial involved 177 adults who were overweight and obese. Among them, 91 (51.4%) were allocated to the IFHP group and 86 (48.6%) were allocated to the HP group. The overall study duration was 6 months (October 2020 to March 2021). The intervention was divided into 2 phases: supervised (3 months) and unsupervised (3 months). The data were collected at baseline, after the supervised phase (month 3), and after the unsupervised phase (month 6). Anthropometric (weight, height, waist circumference, and hip circumference) and body composition (body fat percentage, body fat mass, skeletal muscle mass, and visceral fat area) data were measured at all 3 data collection points. Sociodemographic data were obtained using a questionnaire at baseline. RESULTS Most participants were female (147/177, 83.1%) and Malay (141/177, 79.7%). After 3 months, there were significant reductions in weight (difference −1.68; P<.001), BMI (difference −0.62; P<.001), body fat percentage (difference −0.921; P<.001), body fat mass (difference −1.28; P<.001), and visceral fat area (difference −4.227; P=.008) in the IFHP group, whereas no significant changes were observed in the HP group. Compared to baseline, participants in the IFHP group showed a significant decrease in weight (difference −1.428; P=.003), BMI (difference −0.522; P=.005), body fat percentage (difference −1.591; P<.001), body fat mass (difference −1.501; P<.001), visceral fat area (difference −7.130; P<.001), waist circumference (difference −2.304; P=.001), and hip circumference (difference −1.908; P=.002) at month 6. During the unsupervised phase, waist (IFHP difference −3.206; P<.001, HP difference −2.675; P=.004) and hip (IFHP difference −2.443; P<.001; HP difference −2.896; P<.001) circumferences were significantly reduced in both groups (P<.01), whereas skeletal muscle mass (difference 0.208; P=.04) and visceral fat area (difference −2.903; P=.003) were significantly improved in the IFHP group only. No significant difference in the between-group comparison was detected throughout the intervention (all P>.05). CONCLUSIONS A combined IFHP intervention was effective in improving anthropometric outcomes and body composition in adults with overweight and obesity. INTERNATIONAL REGISTERED REPORT RR2-10.2196/33801.